Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Vaccine-induced th17 cells are maintained long-term postvaccination as a distinct and phenotypically stable memory subset.

Lindenstrøm T, Woodworth J, Dietrich J, Aagaard C, Andersen P, Agger EM.

Infect Immun. 2012 Oct;80(10):3533-44. doi: 10.1128/IAI.00550-12. Epub 2012 Jul 30.

PMID:
22851756
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T cells.

Lindenstrøm T, Agger EM, Korsholm KS, Darrah PA, Aagaard C, Seder RA, Rosenkrands I, Andersen P.

J Immunol. 2009 Jun 15;182(12):8047-55. doi: 10.4049/jimmunol.0801592.

PMID:
19494330
[PubMed - indexed for MEDLINE]
Free Article
3.

Synchronization of dendritic cell activation and antigen exposure is required for the induction of Th1/Th17 responses.

Kamath AT, Mastelic B, Christensen D, Rochat AF, Agger EM, Pinschewer DD, Andersen P, Lambert PH, Siegrist CA.

J Immunol. 2012 May 15;188(10):4828-37. doi: 10.4049/jimmunol.1103183. Epub 2012 Apr 13.

PMID:
22504654
[PubMed - indexed for MEDLINE]
Free Article
4.

The M. tuberculosis phosphate-binding lipoproteins PstS1 and PstS3 induce Th1 and Th17 responses that are not associated with protection against M. tuberculosis infection.

Palma C, Spallek R, Piccaro G, Pardini M, Jonas F, Oehlmann W, Singh M, Cassone A.

Clin Dev Immunol. 2011;2011:690328. doi: 10.1155/2011/690328. Epub 2011 Mar 27.

PMID:
21603219
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Nanoparticle conjugation and pulmonary delivery enhance the protective efficacy of Ag85B and CpG against tuberculosis.

Ballester M, Nembrini C, Dhar N, de Titta A, de Piano C, Pasquier M, Simeoni E, van der Vlies AJ, McKinney JD, Hubbell JA, Swartz MA.

Vaccine. 2011 Sep 16;29(40):6959-66. doi: 10.1016/j.vaccine.2011.07.039. Epub 2011 Jul 23.

PMID:
21787826
[PubMed - indexed for MEDLINE]
6.

The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling.

Desel C, Werninghaus K, Ritter M, Jozefowski K, Wenzel J, Russkamp N, Schleicher U, Christensen D, Wirtz S, Kirschning C, Agger EM, Prazeres da Costa C, Lang R.

PLoS One. 2013;8(1):e53531. doi: 10.1371/journal.pone.0053531. Epub 2013 Jan 7.

PMID:
23308247
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Early secreted antigen ESAT-6 of Mycobacterium tuberculosis promotes protective T helper 17 cell responses in a toll-like receptor-2-dependent manner.

Chatterjee S, Dwivedi VP, Singh Y, Siddiqui I, Sharma P, Van Kaer L, Chattopadhyay D, Das G.

PLoS Pathog. 2011 Nov;7(11):e1002378. doi: 10.1371/journal.ppat.1002378. Epub 2011 Nov 10.

PMID:
22102818
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Highly persistent and effective prime/boost regimens against tuberculosis that use a multivalent modified vaccine virus Ankara-based tuberculosis vaccine with interleukin-15 as a molecular adjuvant.

Kolibab K, Yang A, Derrick SC, Waldmann TA, Perera LP, Morris SL.

Clin Vaccine Immunol. 2010 May;17(5):793-801. doi: 10.1128/CVI.00006-10. Epub 2010 Mar 31.

PMID:
20357059
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells.

Kamath AT, Rochat AF, Christensen D, Agger EM, Andersen P, Lambert PH, Siegrist CA.

PLoS One. 2009 Jun 3;4(6):e5771. doi: 10.1371/journal.pone.0005771.

PMID:
19492047
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice.

Wu J, Ma H, Qu Q, Zhou WJ, Luo YP, Thangaraj H, Lowrie DB, Fan XY.

Vaccine. 2011 Oct 13;29(44):7624-30. doi: 10.1016/j.vaccine.2011.08.020. Epub 2011 Aug 19.

PMID:
21856352
[PubMed - indexed for MEDLINE]
11.

Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection.

Fonseca DM, Silva CL, Paula MO, Soares EG, Marchal G, Horn C, Bonato VL.

Immunology. 2007 Aug;121(4):508-17. Epub 2007 Apr 13.

PMID:
17433075
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Interleukin-27 inhibits vaccine-enhanced pulmonary disease following respiratory syncytial virus infection by regulating cellular memory responses.

Zeng R, Zhang H, Hai Y, Cui Y, Wei L, Li N, Liu J, Li C, Liu Y.

J Virol. 2012 Apr;86(8):4505-17. doi: 10.1128/JVI.07091-11. Epub 2012 Feb 1.

PMID:
22301139
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Adjuvant modulation of the cytokine balance in Mycobacterium tuberculosis subunit vaccines; immunity, pathology and protection.

Agger EM, Cassidy JP, Brady J, Korsholm KS, Vingsbo-Lundberg C, Andersen P.

Immunology. 2008 Jun;124(2):175-85. doi: 10.1111/j.1365-2567.2007.02751.x. Epub 2008 Jan 12.

PMID:
18201185
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses.

Mori A, Oleszycka E, Sharp FA, Coleman M, Ozasa Y, Singh M, O'Hagan DT, Tajber L, Corrigan OI, McNeela EA, Lavelle EC.

Eur J Immunol. 2012 Oct;42(10):2709-19. doi: 10.1002/eji.201242372. Epub 2012 Aug 6.

PMID:
22777876
[PubMed - indexed for MEDLINE]
15.

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.

Griffiths KL, Pathan AA, Minassian AM, Sander CR, Beveridge NE, Hill AV, Fletcher HA, McShane H.

PLoS One. 2011;6(8):e23463. doi: 10.1371/journal.pone.0023463. Epub 2011 Aug 26.

PMID:
21887254
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice.

Xu J, Xu W, Chen X, Zhao D, Wang Y.

Vaccine. 2008 Aug 18;26(35):4519-25. doi: 10.1016/j.vaccine.2008.06.044. Epub 2008 Jul 1.

PMID:
18598729
[PubMed - indexed for MEDLINE]
17.

Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.

Aagaard C, Hoang TT, Izzo A, Billeskov R, Troudt J, Arnett K, Keyser A, Elvang T, Andersen P, Dietrich J.

PLoS One. 2009 Jun 16;4(6):e5930. doi: 10.1371/journal.pone.0005930.

PMID:
19529771
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.

Bennekov T, Dietrich J, Rosenkrands I, Stryhn A, Doherty TM, Andersen P.

Eur J Immunol. 2006 Dec;36(12):3346-55.

PMID:
17109467
[PubMed - indexed for MEDLINE]
19.

CD4 and CD8 T cell responses to the M. tuberculosis Ag85B-TB10.4 promoted by adjuvanted subunit, adenovector or heterologous prime boost vaccination.

Elvang T, Christensen JP, Billeskov R, Thi Kim Thanh Hoang T, Holst P, Thomsen AR, Andersen P, Dietrich J.

PLoS One. 2009;4(4):e5139. doi: 10.1371/journal.pone.0005139. Epub 2009 Apr 9.

PMID:
19357780
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

RD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis.

Ansari MA, Zubair S, Mahmood A, Gupta P, Khan AA, Gupta UD, Arora A, Owais M.

PLoS One. 2011;6(8):e22889. doi: 10.1371/journal.pone.0022889. Epub 2011 Aug 11.

PMID:
21853054
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk